DC lawmakers to take up right-to-die legislation next month

The D.C. Council will vote Nov. 1 on a bill that would legalize physician-assisted suicide, reports The Washington Post.

Advertisement

The bill allows physicians to prescribe medication to end a patient’s life if the patient has only six months left to live and is mentally competent.

The council decided to place the bill on its legislative agenda at the start of next month, when it will hold the first of two required votes on the measure, according to the report.

If the bill is approved, Washington, D.C., would be the sixth jurisdiction to legalize physician-assisted suicide, reports The Washington Post. Supporters of the practice contend the measure would allow terminally ill patients to choose when and how they die and to avoid prolonged suffering, according to the article. But opponents argue the practice violates their religious beliefs, advocates for the disabled who fear people will be steered to premature death and medical professionals who believe it violates the Hippocratic oath, the report states.

 

More articles on legal and regulatory news:

Methodist Health denies it improperly deducts pay from nurses for meal breaks
10 latest healthcare industry lawsuits, settlements
Former health clinic CEO sentenced to 18 years in fraud case

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Download Whitepaper

The cost-saving opportunity most health systems overlook

Many hospitals and health systems scrutinize staffing, service lines, and payer contracts for savings. Fewer look at one of their largest assets: real estate.…

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.